{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T17:09:53Z","timestamp":1776964193356,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>In inflammatory bowel disease (IBD) the pathogenetic process is characterized by dysbiosis, increased permeability, translocation, and immune activation. The aim of the present study was to assess the presence of viable bacteria in the blood of patients with IBD and to correlate the findings with clinical characteristics. The study included 28 patients with Crohn\u2019s disease (CD) (median age 38 years, 50% female, biological treatment in 71%) and 19 patients with ulcerative colitis (UC) (median age 45 years, 33% female, biological treatment in 84%). Identification of viable bacteria in the blood was evaluated by optimized cultivation and Sanger sequencing and for quantification real-time PCR was performed. Viable Gram-positive bacteria were detected in 34 IBD patients (72.3%). There were no associations between the presence of bacteria and gender, antibiotic treatment, intake of alcohol, use of PPI, steroids, or biological treatment. The number of bacterial copies was correlated with higher C-reactive protein (CRP) (<jats:italic>p<\/jats:italic>\u2009=\u20090.013). In \u00be of the patients, viable bacteria were identified in the blood despite treatment with biologicals, which indicates a vast barrier defect. This observation also indicates that the disease is still active. To obtain a true deep mucosal healing an intact barrier function is required.<\/jats:p>","DOI":"10.1038\/s41598-025-07535-z","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T08:12:08Z","timestamp":1750839128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Presence of viable gram-positive bacteria in blood of patients with inflammatory bowel disease is not affected by treatment"],"prefix":"10.1038","volume":"15","author":[{"given":"Sanna","family":"Davidson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunjeong","family":"So","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elin","family":"Oscarsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5sa","family":"H\u00e5kansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klas","family":"Sj\u00f6berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"7535_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1053\/j.gastro.2016.10.020","volume":"152","author":"GG Kaplan","year":"2017","unstructured":"Kaplan, G. G. & Ng, S. C. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology 152, 313\u2013321 (2017).","journal-title":"Gastroenterology"},{"key":"7535_CR2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrgastro.2012.152","volume":"9","author":"C Manichanh","year":"2012","unstructured":"Manichanh, C., Borruel, N., Casellas, F. & Guarner, F. The gut microbiota in IBD. Nat. Rev. Gastroenterol. Hepatol. 9, 599\u2013608. https:\/\/doi.org\/10.1038\/nrgastro.2012.152 (2012).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"7535_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00535-013-0777-2","volume":"48","author":"V Leone","year":"2013","unstructured":"Leone, V., Chang, E. B. & Devkota, S. Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases. J. Gastroenterol. 48, 315\u2013321. https:\/\/doi.org\/10.1007\/s00535-013-0777-2 (2013).","journal-title":"J. Gastroenterol."},{"key":"7535_CR4","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","volume":"146","author":"AD Kostic","year":"2014","unstructured":"Kostic, A. D., Xavier, R. J. & Gevers, D. The Microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146, 1489\u20131499. https:\/\/doi.org\/10.1053\/j.gastro.2014.02.009 (2014).","journal-title":"Gastroenterology"},{"key":"7535_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/MIB.0000000000000602","volume":"22","author":"L Putignani","year":"2016","unstructured":"Putignani, L. et al. Gut microbiota dysbiosis as risk and premorbid factors of IBD and IBS along the Childhood-Adulthood transition. Inflamm. Bowel Dis. 22, 487\u2013504. https:\/\/doi.org\/10.1097\/MIB.0000000000000602 (2016).","journal-title":"Inflamm. Bowel Dis."},{"key":"7535_CR6","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.3748\/wjg.15.5287","volume":"15","author":"K Fyderek","year":"2009","unstructured":"Fyderek, K. et al. Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease. World J. Gastroenterol. 15, 5287\u20135294. https:\/\/doi.org\/10.3748\/wjg.15.5287 (2009).","journal-title":"World J. Gastroenterol."},{"key":"7535_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1136\/gutjnl-2012-303207","volume":"2","author":"ME Johansson","year":"2014","unstructured":"Johansson, M. E. et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 2, 281\u2013291. https:\/\/doi.org\/10.1136\/gutjnl-2012-303207 (2014).","journal-title":"Gut"},{"key":"7535_CR8","doi-asserted-by":"publisher","first-page":"703310","DOI":"10.3389\/fcell.2021.703310","volume":"9","author":"R Linares","year":"2021","unstructured":"Linares, R., Franc\u00e9s, R., Guti\u00e9rrez, A. & Juanola, O. Bacterial translocation as inflammatory driver in crohn\u2019s disease. Front. Cell. Dev. Biol. 9, 703310. https:\/\/doi.org\/10.3389\/fcell.2021.703310 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"7535_CR9","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/ibd.20806","volume":"15","author":"A Guti\u00e9rrez","year":"2009","unstructured":"Guti\u00e9rrez, A. et al. Cytokine association with bacterial DNA in serum of patients with inflammatory bowel disease. Inflamm. Bowel Dis. 15, 508\u2013514. https:\/\/doi.org\/10.1002\/ibd.20806 (2009).","journal-title":"Inflamm. Bowel Dis."},{"key":"7535_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/ajg.2016.8","volume":"111","author":"A Guti\u00e9rrez","year":"2016","unstructured":"Guti\u00e9rrez, A. et al. Gut bacterial DNA translocation is an independent risk factor of flare at short term in patients with crohn\u2019s disease. Am. J. Gastroenterol. 111, 529\u2013540. https:\/\/doi.org\/10.1038\/ajg.2016.8 (2016).","journal-title":"Am. J. Gastroenterol."},{"issue":"1)","key":"7535_CR11","doi-asserted-by":"publisher","first-page":"e0170034","DOI":"10.1371\/journal.pone.0170034","volume":"12","author":"S Vrakas","year":"2017","unstructured":"Vrakas, S. et al. Intestinal Bacteria composition and translocation of Bacteria in inflammatory bowel disease. PLoS One. 12 (1)), e0170034. https:\/\/doi.org\/10.1371\/journal.pone.0170034 (2017).","journal-title":"PLoS One"},{"key":"7535_CR12","doi-asserted-by":"publisher","first-page":"10899","DOI":"10.3390\/ijms241310899","volume":"24","author":"J Xu","year":"2023","unstructured":"Xu, J. et al. CRP in outpatients with inflammatory bowel disease is linked to the blood. Microbiota. Int. J. Mol. Sci. 24, 10899. https:\/\/doi.org\/10.3390\/ijms241310899 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"7535_CR13","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3390\/microorganisms9071464","volume":"9","author":"S Panaiotov","year":"2021","unstructured":"Panaiotov, S., Hodzhev, Y., Tsafarova, B., Tolchkov, V. & Kalfin, R. Culturable and Non-Culturable blood microbiota of healthy individuals. Microorganisms 9, 1464. https:\/\/doi.org\/10.3390\/microorganisms9071464 (2021).","journal-title":"Microorganisms"},{"key":"7535_CR14","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/trf.13477","volume":"56","author":"S Pa\u00efss\u00e9","year":"2016","unstructured":"Pa\u00efss\u00e9, S. et al. Comprehensive description of blood Microbiome from healthy donors assessed by 16S targeted metagenomic sequencing. Transfusion 56, 1138\u20131147. https:\/\/doi.org\/10.1111\/trf.13477 (2016).","journal-title":"Transfusion"},{"key":"7535_CR15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3389\/fcimb.2019.00440","volume":"9","author":"DBM Hammad","year":"2020","unstructured":"Hammad, D. B. M., Hider, S. L., Liyanapathirana, V. C. & Tonge, D. P. Molecular characterization of Circulating Microbiome signatures in rheumatoid arthritis. Front. Cell. Infect. Microbiol. 9, 440. https:\/\/doi.org\/10.3389\/fcimb.2019.00440 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"7535_CR16","doi-asserted-by":"publisher","unstructured":"Chang, C. J. et al. Compositional features of distinct microbiota base on serum extracellular vesicle metagenomics analysis in moderate to severe psoriasis patients. Cells 10, 2349. https:\/\/doi.org\/10.3390\/cells10092349   (2021).","DOI":"10.3390\/cells10092349"},{"key":"7535_CR17","doi-asserted-by":"publisher","first-page":"100069","DOI":"10.1016\/j.crmicr.2021.100069","volume":"2","author":"I Mehrotra","year":"2021","unstructured":"Mehrotra, I. et al. Characterization of the blood microbiota in children with Celiac disease. Curr. Res. Microb. Sci. 2, 100069. https:\/\/doi.org\/10.1016\/j.crmicr.2021.100069 (2021).","journal-title":"Curr. Res. Microb. Sci."},{"key":"7535_CR18","doi-asserted-by":"publisher","first-page":"932702","DOI":"10.3389\/fcimb.2022.932702","volume":"12","author":"MU Goraya","year":"2022","unstructured":"Goraya, M. U. et al. Human Circulating bacteria and dysbiosis in non-infectious diseases. Front. Cell. Infect. Microbiol. 12, 932702. https:\/\/doi.org\/10.3389\/fcimb.2022.932702 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"7535_CR19","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.3390\/genes12101636","volume":"12","author":"E Jones","year":"2021","unstructured":"Jones, E. et al. The origin of Plasma-Derived bacterial extracellular vesicles in healthy individuals and patients with inflammatory bowel disease: a pilot study. Genes (Basel). 12, 1636. https:\/\/doi.org\/10.3390\/genes12101636 (2021).","journal-title":"Genes (Basel)"},{"key":"7535_CR20","doi-asserted-by":"publisher","unstructured":"Huang, T-H., Tzeng, Y-L. & Dickson, R. M.  FAST Rapid determinations of antibiotic susceptibility phenotypes using Label-Free cytometry. Cytometry A. 93, 639\u2013648. https:\/\/doi.org\/10.1002\/cyto.a.23370 (2018).","DOI":"10.1002\/cyto.a.23370"},{"key":"7535_CR21","doi-asserted-by":"publisher","first-page":"707515","DOI":"10.3389\/fmicb.2021.707515","volume":"12","author":"P D\u2019Aquila","year":"2021","unstructured":"D\u2019Aquila, P. et al. Microbiome in blood samples from the general population recruited in the MARK-AGE project: a pilot study. Front. Microbiol. 12, 707515. https:\/\/doi.org\/10.3389\/fmicb.2021.707515 (2021).","journal-title":"Front. Microbiol."},{"key":"7535_CR22","first-page":"502098","volume":"07.29","author":"CC Tan","year":"2022","unstructured":"Tan, C. C. et al. No evidence for a common blood Microbiome based on a population study of 9770 healthy humans. BioRxiv 07.29, 502098 (2022).","journal-title":"BioRxiv"},{"key":"7535_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10096-016-2805-7","volume":"36","author":"T Gosiewski","year":"2016","unstructured":"Gosiewski, T. et al. Comprehensive detection and identification of bacterial DNA in the blood of patients with sepsis and healthy volunteers using next-generation sequencing method - the observation of dnaemia. Eur. J. Clin. Microbiol. Infect. Dis. 36, 329\u2013336 (2016).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"7535_CR24","doi-asserted-by":"publisher","first-page":"262","DOI":"10.14740\/jocmr4920","volume":"5","author":"M Kamada","year":"2023","unstructured":"Kamada, M. et al. Characteristics of patients with inflammatory bowel disease who develop bloodstream infection. J. Clin. Med. Res. 5, 262\u2013267. https:\/\/doi.org\/10.14740\/jocmr4920 (2023).","journal-title":"J. Clin. Med. Res."},{"issue":"1","key":"7535_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13099-021-00408-6","volume":"13","author":"J Gruszecka","year":"2021","unstructured":"Gruszecka, J. & Filip, R. Are hospitalized patients with inflammatory bowel disease at increased risk of invasive bacterial infections? Results from POLIBD 3-year cohort study. Gut Pathog. 13 (1), 12. https:\/\/doi.org\/10.1186\/s13099-021-00408-6 (2021).","journal-title":"Gut Pathog"},{"key":"7535_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/00365540500449826","volume":"38","author":"A Sullivan","year":"2006","unstructured":"Sullivan, A. & Nord, C. E. Probiotic lactobacilli and bacteraemia in Stockholm. Scand. J. Infect. Dis. 38, 327\u2013331. https:\/\/doi.org\/10.1080\/00365540500449826 (2006).","journal-title":"Scand. J. Infect. Dis."},{"key":"7535_CR27","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/clinids\/22.3.564","volume":"22","author":"M Saxelin","year":"1996","unstructured":"Saxelin, M. et al. Lactobacilli and bacteremia in Southern finland, 1989\u20131992. Clin. Infect. Dis. 22, 564\u2013566. https:\/\/doi.org\/10.1093\/clinids\/22.3.564 (1996).","journal-title":"Clin. Infect. Dis."},{"key":"7535_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1574-695X.2010.00662.x","volume":"59","author":"YM Vissers","year":"2010","unstructured":"Vissers, Y. M. et al. Differential effects of Lactobacillus acidophilus and Lactobacillus plantarum strains on cytokine induction in human peripheral blood mononuclear cells. FEMS Immunol. Med. Microbiol. 59, 60\u201370. https:\/\/doi.org\/10.1111\/j.1574-695X.2010.00662.x (2010).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"7535_CR29","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1038\/s41598-018-25514-5","volume":"8","author":"MS Cho","year":"2018","unstructured":"Cho, M. S. et al. Understanding the ontogeny and succession of Bacillus velezensis and B. Subtilis subsp. Subtilis by focusing on Kimchi fermentation. Sci. Rep. 8, 7045. https:\/\/doi.org\/10.1038\/s41598-018-25514-5 (2018).","journal-title":"Sci. Rep."},{"key":"7535_CR30","doi-asserted-by":"publisher","first-page":"7653","DOI":"10.1039\/c9fo01651a","volume":"10","author":"A Fu","year":"2019","unstructured":"Fu, A. et al. Protective effect of Bacillus amyloliquefaciens against Salmonella via polarizing macrophages to M1 phenotype directly and to M2 depended on microbiota. Food Funct. 10, 7653\u20137666. https:\/\/doi.org\/10.1039\/c9fo01651a (2019).","journal-title":"Food Funct."},{"key":"7535_CR31","doi-asserted-by":"publisher","first-page":"14941","DOI":"10.1038\/s41598-023-42128-8","volume":"13","author":"IS Larsen","year":"2023","unstructured":"Larsen, I. S. et al. Bacillus velezensis DSM 33864 reduces clostridioides difficile colonization without disturbing commensal gut microbiota composition. Sci. Rep. 13, 14941. https:\/\/doi.org\/10.1038\/s41598-023-42128-8 (2023).","journal-title":"Sci. Rep."},{"key":"7535_CR32","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1099\/ijsem.0.003654","volume":"69","author":"CH Huang","year":"2019","unstructured":"Huang, C. H. et al. Reclassification of Micrococcus aloeverae and Micrococcus yunnanensis as later heterotypic synonyms of Micrococcus luteus. Int. J. Syst. Evol. Microbiol. 69, 3512\u20133518. https:\/\/doi.org\/10.1099\/ijsem.0.003654 (2019).","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"7535_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.33073\/pjm-2021-030","volume":"70","author":"M Zhu","year":"2021","unstructured":"Zhu, M., Zhu, Q., Yang, Z. & Liang, Z. Clinical characteristics of patients with Micrococcus luteus bloodstream infection in a Chinese Tertiary-Care hospital. Pol. J. Microbiol. 70, 321\u2013326. https:\/\/doi.org\/10.33073\/pjm-2021-030 (2021).","journal-title":"Pol. J. Microbiol."},{"key":"7535_CR34","first-page":"216","volume":"122","author":"RB Schifman","year":"1998","unstructured":"Schifman, R. B., Strand, C. L., Meier, F. A. & Howanitz, P. J. Blood culture contamination: a college of American pathologists Q-Probes study involving 640 institutions and 497134 specimens from adult patients. Arch. Pathol. Lab. Med. 122, 216\u2013221 (1998).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"7535_CR35","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1128\/CMR.00109-13","volume":"27","author":"K Becker","year":"2014","unstructured":"Becker, K., Heilmann, C. & Peters, G. Coagulase-negative Staphylococci. Clin. Microbiol. Rev. 27, 870\u2013926. https:\/\/doi.org\/10.1128\/CMR.00109-13 (2014).","journal-title":"Clin. Microbiol. Rev."},{"key":"7535_CR36","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/clind\/24.4.584","volume":"24","author":"MP Weinstein","year":"1997","unstructured":"Weinstein, M. P. et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin. Infect. Dis. 24, 584\u2013602. https:\/\/doi.org\/10.1093\/clind\/24.4.584 (1997).","journal-title":"Clin. Infect. Dis."},{"key":"7535_CR37","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1053\/gast.2002.35379","volume":"123","author":"CJ Landers","year":"2002","unstructured":"Landers, C. J. et al. Selected loss of tolerance evidenced by crohn\u2019s disease-associated immune responses to auto- and microbial antigens. Gastroenterology 123, 689\u2013699. https:\/\/doi.org\/10.1053\/gast.2002.35379 (2002).","journal-title":"Gastroenterology"},{"key":"7535_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1053\/gast.2000.8519","volume":"119","author":"CL Sutton","year":"2000","unstructured":"Sutton, C. L. et al. Identification of a novel bacterial sequence associated with crohn\u2019s disease. Gastroenterology 119, 23\u201331. https:\/\/doi.org\/10.1053\/gast.2000.8519 (2000).","journal-title":"Gastroenterology"},{"key":"7535_CR39","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/odi.14531","volume":"30","author":"CC Martins","year":"2024","unstructured":"Martins, C. C. et al. Bacteremia following different oral procedures: systematic review and meta-analysis. Oral Dis. 30, 846\u2013854. https:\/\/doi.org\/10.1111\/odi.14531 (2024).","journal-title":"Oral Dis."},{"key":"7535_CR40","doi-asserted-by":"publisher","unstructured":"Kullar, R., Goldstein, E. J. C., Johnson, S. & McFarland, L. V. Lactobacillus bacteremia probiotics. Rev. Microorganisms 11, 896.  https:\/\/doi.org\/10.3390\/microorganisms11040896. (2023).","DOI":"10.3390\/microorganisms11040896"},{"key":"7535_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1472-765X.1995.tb01030.x","volume":"21","author":"M-L Johansson","year":"1995","unstructured":"Johansson, M-L., Quednau, M., Molin, G. & Ahrn\u00e9, S. Randomly amplified polymorphic DNA (RAPD) for rapid typing of Lactobacillus plantarum strains. Lett. Appl. Microbiol. 21, 155\u2013159. https:\/\/doi.org\/10.1111\/j.1472-765X.1995.tb01030.x (1995).","journal-title":"Lett. Appl. Microbiol."},{"key":"7535_CR42","doi-asserted-by":"publisher","first-page":"D633","DOI":"10.1093\/nar\/gkt1244","volume":"42","author":"JR Cole","year":"2014","unstructured":"Cole, J. R. et al. Ribosomal database project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 42, D633\u2013D642. https:\/\/doi.org\/10.1093\/nar\/gkt1244 (2014).","journal-title":"Nucleic Acids Res."},{"key":"7535_CR43","doi-asserted-by":"publisher","unstructured":"Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37. 852\u2013857  (2019). https:\/\/doi.org\/10.1038\/s41587-019-0209-9.","DOI":"10.1038\/s41587-019-0209-9"},{"key":"7535_CR44","first-page":"10","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnetjournal 17, 10\u201312 (2011).","journal-title":"EMBnetjournal"},{"key":"7535_CR45","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: High-resolution sample inference from illumina amplicon data. Nat. Methods. 13, 581\u2013583. https:\/\/doi.org\/10.1038\/nmeth.3869 (2016).","journal-title":"Nat. Methods"},{"key":"7535_CR46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40168-018-0470-z","volume":"6","author":"NA Bokulich","year":"2018","unstructured":"Bokulich, N. A. et al. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2\u2019s q2-feature-classifier plugin. Microbiome 6, 90. https:\/\/doi.org\/10.1186\/s40168-018-0470-z (2018).","journal-title":"Microbiome"},{"key":"7535_CR47","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1017\/S0007114511001036","volume":"106","author":"CL Karlsson","year":"2011","unstructured":"Karlsson, C. L. et al. Effects on weight gain and gut microbiota in rats given bacterial supplements and a high-energy-dense diet from fetal life through to 6 months of age. Br. J. Nutr. 106, 887\u2013895 (2011).","journal-title":"Br. J. Nutr."},{"key":"7535_CR48","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/jcp.2008.061366","volume":"62","author":"MC Collado","year":"2009","unstructured":"Collado, M. C., Donat, E., Ribes-Koninckx, C., Calabuig, M. & Sanz, Y. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J. Clin. Pathol. 62, 264\u2013269. https:\/\/doi.org\/10.1136\/jcp.2008.061366 (2009).","journal-title":"J. Clin. Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07535-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07535-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07535-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T20:01:42Z","timestamp":1751227302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07535-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7535"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-07535-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Swedish Ethical Review Authority (protocol number 2018\u2009\u2212\u2009577 and 2023-05622-02). Written informed consent was obtained from all participating patients. All methods used in this study were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"20283"}}